Salvatore Privitera
CIK: 0001336063
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AtriCure, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 23, 2026ATRC
AtriCure, Inc.
Sale(S)Direct4.5K shares at avg. $60.00$271K - Sep 8, 2026ATRC
AtriCure, Inc.
Sale(S)Direct3.7K shares at avg. $55.00$201K - Sep 2, 2026ATRC
AtriCure, Inc.
Sale(S)Direct7.8K shares at avg. $52.50$408K - Jun 30, 2026ATRC
AtriCure, Inc.
Award(A)Direct636 shares at avg. $23.78$15K - Mar 1, 2026ATRC
AtriCure, Inc.
Tax Payment(F)Direct13.1K shares at avg. $31.26$410K - Mar 1, 2026ATRC
AtriCure, Inc.
Award(A)Direct15.2K shares- - Mar 1, 2026ATRC
AtriCure, Inc.
Award(A)Direct30.4K shares- - Jun 30, 2025ATRC
AtriCure, Inc.
Award(A)Direct822 shares at avg. $25.84$21K - Mar 1, 2025ATRC
AtriCure, Inc.
Award(A)Direct22.6K shares- - Mar 1, 2025ATRC
AtriCure, Inc.
Award(A)Direct6.6K shares- - Mar 1, 2025ATRC
AtriCure, Inc.
Tax Payment(F)Direct8.4K shares at avg. $38.74$325K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 | ATRC AtriCure, Inc. | Sale(S) | 4,519 | $60.00 | $271,140 | Direct |
| Sep 8, 2026 | ATRC AtriCure, Inc. | Sale(S) | 3,657 | $55.00 | $201,135 | Direct |
| Sep 2, 2026 | ATRC AtriCure, Inc. | Sale(S) | 7,763 | $52.50 | $407,558 | Direct |
| Jun 30, 2026 | ATRC AtriCure, Inc. | Award(A) | 636 | $23.78 | $15,124 | Direct |
| Mar 1, 2026 | ATRC AtriCure, Inc. | Tax Payment(F) | 13,127 | $31.26 | $410,350 | Direct |
| Mar 1, 2026 | ATRC AtriCure, Inc. | Award(A) | 15,198 | - | $0 | Direct |
| Mar 1, 2026 | ATRC AtriCure, Inc. | Award(A) | 30,390 | - | $0 | Direct |
| Jun 30, 2025 | ATRC AtriCure, Inc. | Award(A) | 822 | $25.84 | $21,240 | Direct |
| Mar 1, 2025 | ATRC AtriCure, Inc. | Award(A) | 22,586 | - | - | Direct |
| Mar 1, 2025 | ATRC AtriCure, Inc. | Award(A) | 6,579 | - | - | Direct |
| Mar 1, 2025 | ATRC AtriCure, Inc. | Tax Payment(F) | 8,397 | $38.74 | $325,300 | Direct |
1-11 of 11 transactions
About Privitera Salvatore
Privitera Salvatore (SEC CIK 0001336063) files insider reports with the SEC as Chief Technical Officer of AtriCure, Inc. (ATRC).
Signal8 holds 7 ownership filings by Privitera Salvatore, all Form 4s, filed between Mar 4, 2025 and Sep 24, 2026. Those filings report 11 transactions, from Mar 1, 2025 to Sep 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Privitera Salvatore's filings is in MASON, OH.
Recent filings by Privitera Salvatore
- Sep 23, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Sep 8, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Sep 2, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Jun 30, 2026: Grant or award of ATRC shares (Form 4, code A).
- Mar 1, 2026: Tax withholding of ATRC shares (Form 4, code F).
Other insiders filing for AtriCure, Inc. (ATRC)
- GROVES REGINA E, Director
- Dahlquist Karl S., Chief Legal Officer
- Prange Karen, Director
- Yuen Maggie, Director
- CARREL MICHAEL H, President, CEO, & Director
- Doraiswamy Vinayak, Chief Scientific Officer